SOURCE: Velocity International Corp.

November 21, 2005 13:31 ET

Velocity International Announces Patent Application

NASHVILLE, TN -- (MARKET WIRE) -- November 21, 2005 -- Velocity International Corp (OTC: VCYI), Deep Blue, a wholly owned subsidiary, is a Nevada Corporation that is bringing to market a new patent-pending (Application Number 60/685,110), treatment for HIV /AIDS and other viral infectious diseases. Deep Blue's protocols and technology have been in development for over 9 years. Deep Blue's mission is to develop and bring to market innovative technologies for the national and international medical community that will positively impact those who have been infected with viral diseases and introduce cost effective medical solutions for improving the quality of life of their patients

Cautionary Statement:

This news release may contain certain forward-looking statements within the meaning of Section 27A of the Securities and Exchange Act of 1933, as amended, and Section 21E of the Securities and Exchange Act of 1934, as amended, which are intended to be covered by the safe harbors created thereby. Investors are cautioned that all forward-looking statements involve risks and uncertainties. Although Velocity International Corp. believes that the assumptions underlying the forward-looking statements contained herein are reasonable, any assumption could be inaccurate, and therefore, there can be no assurance that the forward-looking statements included herein, the inclusion should not be regarded as a representation by Velocity International Corp, or any other person that the objection and plans of Velocity International corp. will be achieved.

Contact Information

  • Contact:
    Michael Young